Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142Thierry André, Michael J. Overman, Ka Yeung Mark Wong et al.|Annals of Oncology|2022Cited by 253
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal CancerThierry André, Sara Lonardi, Laëtitia Dahan et al.|New England Journal of Medicine|2024Cited by 208